Skip to main content
XCUR
NASDAQ Life Sciences

Exicure Announces CEO, CFO Resignations and Major Board Overhaul

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$4.31
Mkt Cap
$27.471M
52W Low
$3.101
52W High
$15.91
Market data snapshot near publication time

summarizeSummary

Exicure, Inc. announced the resignations of its CEO and CFO, with both positions currently vacant, alongside a significant refresh of its Board of Directors.


check_boxKey Events

  • CEO and President Resignations

    Andy Yoo resigned as Chief Executive Officer and President, effective February 9, 2026.

  • CFO and Secretary Resignations

    Seung Ik Baik resigned as Chief Financial Officer and Secretary, effective February 9, 2026, and received a $150,000 separation payment.

  • Executive Positions Vacant

    The Board has not appointed successors for the CEO and CFO positions, leaving them vacant.

  • Board of Directors Overhaul

    Three directors (Andy Yoo, Seung Ik Baik, and Aejin Hwang) resigned, and three new directors (Jung Kyu Ham, Jung Soo Kim, and Gyeung Seog Cheon) were appointed to the Board, effective February 9, 2026.


auto_awesomeAnalysis

Exicure, Inc. is undergoing a significant leadership and governance shake-up, with both the Chief Executive Officer and Chief Financial Officer resigning simultaneously, leaving their positions vacant. This creates an immediate leadership vacuum and substantial uncertainty regarding the company's strategic direction and operational stability. Concurrently, three directors resigned from the Board, replaced by three new appointees, indicating a major refresh of the company's governance structure. These changes follow a series of substantial share sales by a major shareholder in January, suggesting a potential shift in control or a response to underlying pressures. The $150,000 separation payment to the outgoing CFO is also notable for a company of this market capitalization. Investors should monitor for appointments to the vacant executive roles and any further clarity on the company's future strategy.

At the time of this filing, XCUR was trading at $4.31 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $27.5M. The 52-week trading range was $3.10 to $15.91. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed XCUR - Latest Insights

XCUR
Apr 22, 2026, 7:57 PM EDT
Source: Reuters
Importance Score:
8
XCUR
Apr 10, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
XCUR
Apr 02, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
XCUR
Mar 27, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
7
XCUR
Mar 27, 2026, 4:40 PM EDT
Filing Type: 8-K
Importance Score:
7
XCUR
Mar 25, 2026, 4:42 PM EDT
Filing Type: 10-K
Importance Score:
9
XCUR
Mar 25, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
9
XCUR
Mar 25, 2026, 4:18 PM EDT
Source: GlobeNewswire
Importance Score:
9
XCUR
Feb 17, 2026, 5:25 PM EST
Filing Type: 8-K
Importance Score:
8
XCUR
Feb 10, 2026, 4:25 PM EST
Filing Type: 8-K
Importance Score:
9